|
|
Blood, 1 April 2005, Vol. 105, No. 7, pp. 2869-2876.
Prepublished online as a Blood First Edition Paper on December 7, 2004; DOI 10.1182/blood-2004-08-2981.
Previous Article | Next Article 
Submitted August 2, 2004
Accepted November 30, 2004
Ephrin-A1 binding to CD4+ T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2
Hans-Christian Aasheim*, Jan Delabie, and Eivind F Finne
Department of Immunology, The Norwegian Radium Hospital, Oslo, Norway
Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway
* Corresponding author; email: h.c.asheim{at}labmed.uio.no.
Eph receptors, the largest subfamily of receptor tyrosine kinases, and their ephrin ligands are important mediators of cell-cell communication regulating cell attachment, shape and mobility. Here we demonstrate that CD4+ T lymphocytes express the EphA1 and EphA4 receptors, and that these cells bind the ligand ephrin-A1. Further we show ephrin-A1 expression in vivo on high endothelial venules (HEV) endothelial cells. Ephrin-A1 binding to CD4+ T cells stimulates both SDF-1 and MIP3 mediated chemotaxis. In line with the increased chemotactic response, increased actin polymerization is observed in particular with the combination of ephrin-A1 and SDF-1 . Signaling through EphA receptors induces intracellular tyrosine phosphorylation. In particular PYK2 is phosphorylated on tyrosine residues 402 and 580. Ephrin-A1-induced chemotaxis and intracellular tyrosine phosphorylation, including EphA1 and Pyk2, was inhibited by Tyrphostin-A9. In conclusion, ligand engagement of EphA receptors on CD4+ T cells stimulates chemotaxis, induces intracellular tyrosine phosphorylation and affects actin polymerization. This, together with our finding that ephrin-A1 is expressed by HEV, suggests a role for Eph receptors in transendothelial migration.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Jiang, T. Freywald, J. Webster, D. Kozan, R. Geyer, J. DeCoteau, A. Narendran, and A. Freywald
In Human Leukemia Cells Ephrin-B-Induced Invasive Activity Is Supported by Lck and Is Associated with Reassembling of Lipid Raft Signaling Complexes
Mol. Cancer Res.,
February 1, 2008;
6(2):
291 - 305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kitamura, Y. Kabuyama, A. Kamataki, M. K. Homma, H. Kobayashi, S. Aota, S.-i. Kikuchi, and Y. Homma
Enhancement of lymphocyte migration and cytokine production by ephrinB1 system in rheumatoid arthritis
Am J Physiol Cell Physiol,
January 1, 2008;
294(1):
C189 - C196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Pfaff, U. Fiedler, and H. G. Augustin
Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking
J. Leukoc. Biol.,
October 1, 2006;
80(4):
719 - 726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Korff, G. Dandekar, D. Pfaff, T. Fuller, W. Goettsch, H. Morawietz, F. Schaffner, and H. G. Augustin
Endothelial EphrinB2 Is Controlled by Microenvironmental Determinants and Associates Context-Dependently With CD31
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2006;
26(3):
468 - 474.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |